Search
Now showing items 21-40 of 49
Biomaterials for Tissue Repair and Regeneration at Missouri S&T
(2010-03)
Biomaterials are critically important to future developments in the life sciences. They provide a backbone for biomedical research in academia and industry, and are a key component of reconstructive medical and dental research as well as patient...
Experiences in Patenting, Licensing and Commercialization of Radiopharmaceuticals
(2010-02)
three different approaches in developing corporate agreements that were successful in translating MU life sciences research into radiopharmaceuticals that are for use as diagnostic and therapeutic applications in human patients....
In silico Compound Screening for Drug Discovery in the “Cloud”
(2010-03)
The need to identify new small molecules and novel binding partners for known bioactive sites remains a constant in drug development. We are aiding VaSSA Informatics in creating informatics methods used to identify ...
The “Male Pill”: The Learning Curve from Basic Science to the Drug Development Pipeline and the Strength of Interdisciplinary Collaboration
(2010-03)
contraceptive methods remain the most widely used. There are many couples where the female cannot use existing methods. For the male, effective contraceptive methods are limited to condoms and vasectomy. NIH, WHO, and the National Academy of Science Institute...
Genetically-modified animals: powerful tools for biomedical research
(2010)
The University of Missouri houses three National Institutes of Health (NIH), National Center for Research Resources (NCRR) animal resource centers. These animal resource centers are: (1) the Mutant Mouse Regional Resource Center (MMRRC); (2) the Rat...
Patent litigation issues
(2010-03)
Joe Mahoney addressed issues of patent law and patent infringement, citing several examples from the pharmaceutical industry.
Comparative Ophthalmology - scientific discovery and innovation create synergies for veterinary and human medicine
(2010-03)
of vision loss. Many technological innovations have been made which give doctors and scientists unprecedented insights to mechanisms of the eye and effects of treatment in animal models and humans. This presentation will briefly touch on recent...
Integrating academic research, clinical research and private practice: a unique opportunity for translational medicine
(2010-03)
researched to develop new therapy approaches urgently needed by physicians in the US and worldwide, transferring basic science findings seamlessly into practical use with patients....
Navigating the FDA and understanding medical device preemption
(2010-03)
FDA's Center for Devices and Radiological Health (CDRH) is responsible for regulating firms who manufacture, repackage, relabel, and/or import medical devices sold in the United States. In addition, CDRH regulates ...
Navigating the two-way street of comparative oncology
(2010)
Companion animals offer a unique model for study of spontaneously occurring cancer for many reasons. Our pets share our environment, thus may have similar exposure to environmental carcinogens. The technology for diagnosis ...
Training Tomorrows Entrepreneurs Today
(2010-02)
and innovation. Additionally, the program is dedicated to the development and facilitation of interdisciplinary collaboration between faculty and students to increase innovation at the University of Missouri. With the financial support of the Department...
New Insights Revealed by Genetic Studies and the Future of Treating Bone Health Related Issues
(2010-03)
This presentation will examine the major role played by genetic studies in the identification of a fundamental pathway, the Wnt/β-catenin signaling pathway, and it's now appreciated multiple roles in bone cell biology. Specifically I will discuss...
Academic and Commercial Nanomedicine
(2010-03)
The goal of Nanomedicine is to develop new diagnostic and therapeutic agents derived from fundamental discoveries in nanotechnology that can be applied safely and efficaciously in the treatment of human diseases. We have ...
Organ printing: a novel tissue engineering paradigm
(2010)
Engineering new tissues, ideally from the patient's own body cells to prevent rejection by the immune system, is a rapidly growing field that rests on three pillars: cells, supporting structures (or scaffold) and stimulating ...
Functional MRI Studies of Health Behaviors
(2010-03)
and economic well-being at both the individual and national level. For example, health problems related to obesity, such as Type 2 diabetes, are expected to continue to rise and, for the first time in modern history, life expectancies in the US are anticipated...
High-throughput genomics and the Sword of Damocles
(2010-03)
is institutional in nature since no institution can afford the disenfranchisement of a large proportion of its life sciences faculty whom are not bioinformaticians or computer systems analysts. Unless universities and corporate research entities rapidly invest...
The Vision of the International Institute of Nano and Molecular Medicine (I2NM2)
(2010-02)
The International Institute of Nano and Molecular Medicine (I2NM2) of the University of Missouri-Columbia is embarking upon an in-depth study of cancer therapy using the boron neutron capture reaction, the only binary radiation therapy of its type...
Canine Neurodegenerative Diseases: A Bridge from Bench to Health for Humans and their Companions
(2010)
. The Comparative Neurology Program at the University of Missouri, College of Veterinary Medicine has applied this approach to identify the genes responsible for numerous developmental and degenerative diseases of the nervous system. These include seizures disorders...
Rapid label-free diagnostics for biomedical applications using advances in optics nanotechnology
(2010-03)
A new highly sensitive sensor technology has the potential to simplify medical diagnostic tests by significantly reducing operation complexity compared to standard tests such as enzyme-linked immunoassays. Sensor elements ...
Commercialization of novel biomarkers of male fertility in humans and farm animals
(2010-03)
Each year, US infertility clinics treat 135,000 couples who fail to conceive naturally. Up to 40% of these infertility cases can be attributed to male infertility stemming from poor sperm quality. An additional 20% of couples present at the clinic...